Cilostazol-d4 structure
|
Common Name | Cilostazol-d4 | ||
---|---|---|---|---|
CAS Number | 1215541-47-1 | Molecular Weight | 373.49 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H23D4N5O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Cilostazol-d4Cilostazol-d4 is deuterium labeled Cilostazol. Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM[1][2]. |
Name | CILOSTAZOL-D4 |
---|
Description | Cilostazol-d4 is deuterium labeled Cilostazol. Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
[3]. Schr?r K. The pharmacology of cilostazol. Diabetes Obes Metab. 2002 Mar;4 Suppl 2:S14-9. |
Molecular Formula | C20H23D4N5O2 |
---|---|
Molecular Weight | 373.49 |